“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.
A trace element marketed as an appetite suppressant and fat burner. It is also one of the most extensively tested slimming supplements — and the total amount of it weighs less than a kilo.
Loose stools, dizziness, headaches and hives have been reported in clinical trials, although meta-analyses have not identified an increased risk of adverse effects at standard doses. Medical advice is essential for those with treated diabetes: chromium affects blood glucose levels and its effect is additive to that of the treatment. In women with polycystic ovary syndrome, a meta-analysis of six trials reports a significant increase in total and free testosterone. It is also important to note – and this is key – that the more chromium is tested, the less remains. An umbrella review of eight meta-analyses found no effect on total cholesterol, LDL, HDL or triglycerides. A meta-analysis of ten trials found no effect on blood pressure. A dose-response meta-analysis of fourteen trials found no effect on body fat, BMI, waist circumference or weight in people with diabetes. In 36 men who undertook eight weeks of strength training, strength and lean body mass increased independently of chromium. Furthermore, a 2019 review concluded that neither the trials, nor the meta-analyses, nor the systematic reviews have shown any clinically significant effect in humans, with the mechanism of action still unclear.
Trials use between 200 and 1,000 µg per day, most commonly in the form of chromium picolinate — the most widely studied form. Dietary intake meets requirements in the vast majority of cases: the only deficiency documented here occurred during long-term parenteral nutrition.
An isolated chromium deficiency, which has been little documented to date, can lead to glucose intolerance, an inability to use glucose for energy, and even neuropathy, even with normal insulin levels.
This systematic review and meta-analysis evaluated the effect of chromium supplementation on cardiometabolic risk factors in overweight and obese patients. The study included 20 trials and showed that chromium significantly reduced fasting blood glucose, HOMA-IR, and insulin. Slight decreases were also observed in lipid profiles and anthropometric measurements, suggesting a positive role in blood glucose control and the improvement of liver enzymes.
Monfared V, Rashin H, Malekinejad S, Sheikhi L, Yousefi M, Vakili MA, Hasani M. — Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) (2025) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more